Compra por Suministro de Medicamentos con Biosimilaridad Xxiv
La necesidad de comprar “MEDICAMENTOS” para su entrega a los pacientes atendidos en el Hospital Las Higueras
9 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058132-290-SE26 | 23-02-2026 | Sandoz Chile SpA | $588.672 |
| 1058132-15382-SE25 | 09-12-2025 | Novo Nordisk Farmaceutica Limitada | $1.223.320 |
| 1058132-15381-SE25 | 03-12-2025 | Novo Nordisk Farmaceutica Limitada | $33.129.600 |
| 1058132-15309-SE25 | 21-11-2025 | Sandoz Chile SpA | $10.795.174 |
| 1058132-15054-SE25 | 27-10-2025 | Sandoz Chile SpA | $5.886.716 |
| 1058132-14991-SE25 | 10-10-2025 | Novo Nordisk Farmaceutica Limitada | $2.484.720 |
| 1058132-14965-SE25 | 08-10-2025 | Novo Nordisk Farmaceutica Limitada | $458.745 |
| 1058132-14873-SE25 | 24-09-2025 | Sandoz Chile SpA | $2.623.950 |
| 1058132-14822-SE25 | 11-09-2025 | Novo Nordisk Farmaceutica Limitada | $305.830 |
| 1058132-14656-SE25 | 21-08-2025 | Sandoz Chile SpA | $12.432.281 |
| 1058132-14616-SE25 | 07-08-2025 | Novo Nordisk Farmaceutica Limitada | $61.166 |
| 1058132-14487-SE25 | 23-07-2025 | Sandoz Chile SpA | $5.892.440 |
| 1058132-14282-SE25 | 19-06-2025 | Sandoz Chile SpA | $2.623.950 |
| 1058132-14148-SE25 | 30-05-2025 | Aventis Pharma Holding Gmbh | $3.097.570 |
| 1058132-14161-SE25 | 29-05-2025 | Novo Nordisk Farmaceutica Limitada | $244.664 |
| 1058132-14127-SE25 | 28-05-2025 | Sandoz Chile SpA | $5.886.716 |
| 1058132-14073-SE25 | 26-05-2025 | Sandoz Chile SpA | $983.981 |
| 1058132-13966-SE25 | 08-05-2025 | Novo Nordisk Farmaceutica Limitada | $244.664 |
| 1058132-13881-SE25 | 25-04-2025 | Aventis Pharma Holding Gmbh | $9.292.710 |
| 1058132-13834-SE25 | 24-04-2025 | Sandoz Chile SpA | $6.867.835 |
| 1058132-13802-SE25 | 17-04-2025 | Novo Nordisk Farmaceutica Limitada | $244.664 |
| 1058132-10292-SE25 | 24-03-2025 | Aventis Pharma Holding Gmbh | $15.487.850 |
| 1058132-10255-SE25 | 20-03-2025 | Sandoz Chile SpA | $4.908.458 |
| 1058132-10128-SE25 | 05-03-2025 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $20.706.000 |
| 1058132-10113-SE25 | 27-02-2025 | Novo Nordisk Farmaceutica Limitada | $366.996 |
| 1058132-10037-SE25 | 21-02-2025 | Novo Nordisk Farmaceutica Limitada | $9.193.464 |
| 1058132-10003-SE25 | 20-02-2025 | Sandoz Chile SpA | $1.311.975 |
| 1058132-10022-SE25 | 20-02-2025 | Fresenius Kabi Chile Limitada | $5.355.000 |
| 1058132-6316-SE25 | 31-01-2025 | Novo Nordisk Farmaceutica Limitada | $366.996 |
| 1058132-4091-SE25 | 27-01-2025 | Fresenius Kabi Chile Limitada | $2.356.200 |
| 1058132-3998-SE25 | 22-01-2025 | Fresenius Kabi Chile Limitada | $4.498.200 |
| 1058132-3989-SE25 | 22-01-2025 | Novo Nordisk Farmaceutica Limitada | $1.656.480 |
| 1058132-4001-SE25 | 22-01-2025 | Sandoz Chile SpA | $655.988 |
| 1058132-113-SE25 | 20-01-2025 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $20.706.000 |
| 1058132-99-SE25 | 17-01-2025 | Novo Nordisk Farmaceutica Limitada | $1.656.480 |
| 1058132-69-SE25 | 13-01-2025 | Novo Nordisk Farmaceutica Limitada | $152.915 |
| 1058132-63-SE25 | 13-01-2025 | Novo Nordisk Farmaceutica Limitada | $3.312.960 |
| 1058132-2665-SE24 | 02-01-2025 | Aventis Pharma Holding Gmbh | $4.646.355 |
| 1058132-2635-SE24 | 30-12-2024 | Fresenius Kabi Chile Limitada | $2.142.000 |
| 1058132-2563-SE24 | 13-12-2024 | Novo Nordisk Farmaceutica Limitada | $2.484.720 |
| 1058132-2524-SE24 | 06-12-2024 | Novo Nordisk Farmaceutica Limitada | $3.312.960 |
Fuente original:ficha mercadopublico.cl
